Last Updated: August 9, 2026

PATHOCIL Drug Patent Profile

Name: PATHOCIL Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Pathocil, and what generic alternatives are available?

Pathocil is a drug marketed by Wyeth Ayerst and is included in two NDAs.

The generic ingredient in PATHOCIL is dicloxacillin sodium. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Pathocil

A generic version of PATHOCIL was approved as dicloxacillin sodium by TEVA on June 3^rd, 1982.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for PATHOCIL?
What are the global sales for PATHOCIL?
What is Average Wholesale Price for PATHOCIL?

Summary for PATHOCIL

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	1
Patent Applications:	587
DailyMed Link:	PATHOCIL at DailyMed

Drug patent expirations by year for PATHOCIL

US Patents and Regulatory Information for PATHOCIL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wyeth Ayerst	PATHOCIL	dicloxacillin sodium	CAPSULE;ORAL	050011-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Wyeth Ayerst	PATHOCIL	dicloxacillin sodium	CAPSULE;ORAL	050011-003	Mar 28, 1983		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Wyeth Ayerst	PATHOCIL	dicloxacillin sodium	FOR SUSPENSION;ORAL	050092-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.